Literature DB >> 9228503

Hypermobility in two Dutch school populations.

D G Rikken-Bultman1, L Wellink, P W van Dongen.   

Abstract

OBJECTIVE: To determine the presence of hypermobility and differences between females and males in a Dutch population. STUDY
DESIGN: Joint mobility was measured in a primary and a secondary school population. Beighton and Biro measurements were used. The data were evaluated statistically.
RESULTS: Using the Beighton score, 15.5% of group I (n = 252; 4-13 years) and 13.4% of group II (n = 658; 12-17 years) were hypermobile. Hypermobility was found more in females than in males, the difference being significant in the older group. Overall, hypermobility did not significantly diminish with ageing, although the individual joints did not show a significant decrease in mobility with ageing. Hypermobility was significantly more pronounced at the non-dominant body side in both groups. The Quetelet-index did not show a significant relation to hypermobility.
CONCLUSION: Hypermobility was found more in females than in males, with a trend of decrease of hypermobility with ageing. The non-dominant body side proved to be more hypermobile and the Quetelet-index did not show a relation to hypermobility. Beighton's measurements proved best, since Biro considers the two body sides being equal.

Mesh:

Year:  1997        PMID: 9228503     DOI: 10.1016/s0301-2115(97)02745-0

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  28 in total

1.  Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome.

Authors:  Manon C Zweers; Jim Bristow; Peter M Steijlen; Willow B Dean; Ben C Hamel; Marisol Otero; Martina Kucharekova; Jan B Boezeman; Joost Schalkwijk
Journal:  Am J Hum Genet       Date:  2003-07       Impact factor: 11.025

2.  ACL Research Retreat V: an update on ACL injury risk and prevention, March 25-27, 2010, Greensboro, NC.

Authors:  Sandra J Shultz; Randy J Schmitz; Anh-Dung Nguyen; Ajit M Chaudhari; Darin A Padua; Scott G McLean; Susan M Sigward
Journal:  J Athl Train       Date:  2010 Sep-Oct       Impact factor: 2.860

3.  Relationship of Q angle and joint hypermobility and Q angle values in different positions.

Authors:  Omer Faruk Sendur; Gulcan Gurer; Tuncay Yildirim; Emine Ozturk; Ali Aydeniz
Journal:  Clin Rheumatol       Date:  2005-10-06       Impact factor: 2.980

4.  Is joint hypermobility important in prepubertal children?

Authors:  Pelin Yazgan; Iclal Geyikli; Dost Zeyrek; Lutfu Baktiroglu; Mehmet Ali Kurcer
Journal:  Rheumatol Int       Date:  2008-01-18       Impact factor: 2.631

5.  Anatomical and structural factors.

Authors: 
Journal:  J Athl Train       Date:  2008 Sep-Oct       Impact factor: 2.860

6.  Association of generalized joint hypermobility with a history of glenohumeral joint instability.

Authors:  Kenneth L Cameron; Michele L Duffey; Thomas M DeBerardino; Paul D Stoneman; Christopher J Jones; Brett D Owens
Journal:  J Athl Train       Date:  2010 May-Jun       Impact factor: 2.860

7.  Hypermobility Frequency in School Children: Relationship With Idiopathic Scoliosis, Age, Sex and Musculoskeletal Problems.

Authors:  Sinem Bozkurt; Gülseren Kayalar; Nihal Tezel; Tuba Güler; Bilge Kesikburun; Merve Denizli; Sefa Tan; Hürriyet Yilmaz
Journal:  Arch Rheumatol       Date:  2018-11-30       Impact factor: 1.472

Review 8.  Vesicoureteral reflux and the extracellular matrix connection.

Authors:  Fatima Tokhmafshan; Patrick D Brophy; Rasheed A Gbadegesin; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

9.  The relationship between benign joint hypermobility syndrome and carpal tunnel syndrome.

Authors:  I Aktas; D Ofluoglu; T Albay
Journal:  Clin Rheumatol       Date:  2008-06-05       Impact factor: 2.980

10.  Assessment of the relationship between joint laxity and migration of the hip in children with Down syndrome.

Authors:  R Eshuis; M Boonzaaijer; H van Wieringen; J E H Pruijs; R J B Sakkers
Journal:  J Child Orthop       Date:  2012-09-18       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.